Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients

Monostory Katalin; Toth Katalin; Kiss Adam; Hafra Edit; Csikany Nora; Paulik Jozsef; Sarvary Eniko; Kobori Laszlo

首页> 外文期刊>British Journal of Clinical Pharmacology >Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients

【24h】

Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients

机译：通过调整肝移植患者的供体CYP3A状态来个性化初始钙调神经磷酸酶抑制剂的剂量

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AIMS

机译：AIMS

著录项

来源
《British Journal of Clinical Pharmacology》 |2015年第6期|共9页
作者
Monostory Katalin; Toth Katalin; Kiss Adam; Hafra Edit; Csikany Nora; Paulik Jozsef; Sarvary Eniko; Kobori Laszlo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
ciclosporin; CYP3A status; CYP3A4 expression; CYP3A5 genotyping; liver transplant recipients; tacrolimus;

机译：环孢素;CYP3A状态;CYP3A4表达;CYP3A5基因分型;肝移植受者;他克莫司;

相似文献

外文文献
中文文献
专利

1. Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients [J] . Monostory Katalin, Toth Katalin, Kiss Adam, British Journal of Clinical Pharmacology . 2015,第6期

机译：通过调整肝移植患者的供体CYP3A状态来个性化初始钙调神经磷酸酶抑制剂的剂量
2. Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A-status in liver transplant recipients [J] . Csikany Nora, Kiss Adam, Deri Mate, British Journal of Clinical Pharmacology . 2021,第4期

机译：个性化他克莫司给药在肝脏移植受者中的供体CYP3A状态调整的临床意义
3. Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A‐status in liver transplant recipients [J] . Nóra Csikány, ádám Kiss, Máté Déri, British journal of clinical pharmacology . 2021,第4期

机译：个性化他克莫司给药在肝脏移植受者中的供体CYP3A状态调整的临床意义
4. UTILIZATION OF AN EMR-BIOREPOSITORY TO IDENTIFY THE GENETIC PREDICTORS OF CALCINEURIN-INHIBITOR TOXICITY IN HEART TRANSPLANT RECIPIENTS [C] . MATTHEW OETJENS, WILLIAM S. BUSH, KELLY A. BIRDWELL, Pacific Symposium on Biocomputing . 2014

机译：利用EMR-BioRepository以鉴定心脏移植受者钙素抑制剂毒性的遗传预测因子
5. Pharmacokinetics of intraarterial calcineurin inhibitor delivery to composite tissue: A study of regional and systemic advantages of intraarterial delivery of calcineurin inhibitors (cyclosporine and tacrolimus) to a vascularly isolated rabbit forelimb. [D] . Shirbacheh, Mansour V. 1999

机译：动脉钙调神经磷酸酶抑制剂向复合组织递送的药代动力学：钙调神经磷酸酶抑制剂（环孢素和他克莫司）向血管分离的兔前肢的动脉内递送的区域和全身优势的研究。
6. Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A‐status in liver transplant patients [O] . Katalin Monostory, Katalin Tóth, Ádám Kiss, 2015

机译：通过调整肝移植患者的供体CYP3A状态来个性化初始钙调神经磷酸酶抑制剂的剂量
7. Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation [O] . Gerhardt, T, Terjung, B, Knipper, P, 2009

机译：肝移植后肾功能不全-轻度肾上腺素抑制剂与钙调神经磷酸酶抑制剂在肝移植后轻度肾功能不佳的患者中抑制免疫抑制的先导试验

Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients

摘要

著录项

相似文献

相关主题

期刊订阅